Two MER2-negative individuals with the same novel CD151 mutation and evidence for clinical significance of anti-MER2

Transfusion

Volumn 48, Issue 9, 2008, Pages 1912-1916

  Karamatic Crew, Vanja ^a   Poole, Joyce ^b   Long, Shannon ^b   Warke, Nicole ^b   Colavecchia, Connie ^b   Burton, Nicholas ^b   Moulds, Marilyn ^b   Schlanser, Gloria ^b   Wilson, Laura ^b   Noumsi, Ghislain ^b   Moulds, Joann M ^b   Moulds, John J ^b   Daniels, Geoff ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; BLOOD GROUP MER 2 ANTIBODY; BLOOD GROUP MER 2 ANTIGEN; TETRASPANIN; UNCLASSIFIED DRUG;

AGED; AMINO ACID SUBSTITUTION; ANTIBODY DETECTION; ARTICLE; BLOOD GROUP RAPH SYSTEM; BLOOD GROUP SYSTEM; BLOOD TRANSFUSION REACTION; CASE REPORT; CD 151 GENE; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; ETHNICITY; FEMALE; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; HOMOZYGOTE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; SEROLOGY;

AGED, 80 AND OVER; ANTIGENS, CD; BLOOD GROUP ANTIGENS; BLOOD TRANSFUSION; FEMALE; HUMANS; ISOANTIBODIES; MODELS, MOLECULAR; MUTATION; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, SECONDARY;

EID: 50849095438     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01792.x     Document Type: Article

References (12)

1. Daniels GL, Fletcher A, Garratty G, Henry S, Jørgensen J, Judd WJ, Levene C, Lomas-Francis C, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Sistonen P, Smart E, Tani Y, Wendel S, Zelinski T. Blood group terminology 2004: from the ISBT Committee on Terminology for Red Cell Surface Antigens. Vox Sang 2004 87 : 304 16.
2. Karamatic Crew V, Burton N, Kagan A, Green CA, Levene C, Flinter F, Brady RL, Daniels G, Anstee DJ. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 2004 104 : 2217 23.
3. Daniels GL, Tippett P, Palmer DK, Miller YE, Geyer D, Jones C. MER2: a red cell polymorphism defined by monoclonal antibodies. Vox Sang 1987 52 : 107 10.
4. Daniels GL, Levene C, Berrebi A, Schechter Y, Moulds M, Sela R, Poole J, Lacey P, Atkins CJ. Human alloantibodies detecting a red cell antigen apparently identical to MER2. Vox Sang 1988 55 : 161 4.
5. Kagan A, Feld S, Chemke J, Bar-Khayim Y. Occurrence of hereditary nephritis, pretibial epidermolysis bullosa and beta-thalassemia minor in two siblings with end-stage renal disease. Nephron 1988 49 : 331 2.
6. Brecher M. Technical manual. 15th ed. Bethesda, MD : AABB 2005. p. 756 67.
7. Gallagher MT, Branch DR, Mison A, Petz LD. Evaluation of reticuloendothelial function in autoimmune hemolytic anemia using an in vitro assay of monocyte-macrophage interaction with erythrocytes. Exp Hematol 1983 11 : 82 9.
8. Branch DR, Gallagher MT, Mison AP, Sy Siok Hian AL, Petz LD. In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes. Br J Haematol 1984 56 : 19 29.
9. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993 26 : 283 91.
10. Kazarov AR, Yang X, Stipp CS, Sehgal B, Hemler ME. An extracellular site on tetraspanin CD151 determines α3 and α6 integrin-dependent cellular morphology. J Cell Biol 2002 158 : 1299 309.
11. Daniels GL, Green CA, Powell RM, Ward T. Hemagglutination-inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor. Transfusion 1998 38 : 332 6.
12. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007 21 : 58 71.